The new PubMed site will become the default in mid-May. Click here to try it now! Frequently asked questions
Format

Send to

Choose Destination
J Biomed Sci. 2019 May 8;26(1):32. doi: 10.1186/s12929-019-0528-7.

Green tea extract catechin improves cardiac function in pediatric cardiomyopathy patients with diastolic dysfunction.

Quan J1,2,3,4, Jia Z1,2,3,4, Lv T1,2,3,4, Zhang L1,2,3,4, Liu L1,2,3,4, Pan B1,2,3,4, Zhu J2,3,4, Gelb IJ5, Huang X6, Tian J7,8,9,10.

Author information

1
Department of Cardiology, Children's Hospital of Chongqing Medical University, 136 Zhongshan Er Road, Yu Zhong District, Chongqing, 400014, China.
2
Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China.
3
China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing, China.
4
Chongqing Key Laboratory of Pediatrics, Chongqing, China.
5
Charlie E. Schmidt College of Medicine, Florida Atlantic University, 777 Glades Road, Boca Raton, FL, 33431, USA.
6
Charlie E. Schmidt College of Medicine, Florida Atlantic University, 777 Glades Road, Boca Raton, FL, 33431, USA. [email protected].
7
Department of Cardiology, Children's Hospital of Chongqing Medical University, 136 Zhongshan Er Road, Yu Zhong District, Chongqing, 400014, China. [email protected].
8
Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China. [email protected].
9
China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing, China. [email protected].
10
Chongqing Key Laboratory of Pediatrics, Chongqing, China. [email protected].

Abstract

BACKGROUND:

Our previous studies have demonstrated that Ca2+ desensitizing catechin could correct diastolic dysfunction in experimental animals with restrictive cardiomyopathy. In this study, it is aimed to assess the effects of green tea extract catechin on cardiac function and other clinical features in pediatric patients with cardiomyopathies.

METHODS:

Twelve pediatric cardiomyopathy patients with diastolic dysfunction were enrolled for the study. Echocardiography, ECG, and laboratory tests were performed before and after the catechin administration for 12 months. Comparison has been made in these patients before and after the treatment with catechin. Next Generation Sequencing was conducted to find out the potential causative gene variants in all patients.

RESULTS:

A significant decrease of isovolumetric relaxation time (115 ± 46 vs 100 ± 42 ms, P = 0.047 at 6 months; 115 ± 46 vs 94 ± 30 ms, P = 0.033 at 12 months), an increase of left ventricle end diastolic volume (40 ± 28 vs 53 ± 28 ml, P = 0.028 at 6 months; 40 ± 28 vs 48 ± 33 ml, P = 0.011 at 12 months) and stroke volume (25 ± 16 vs 32 ± 17 ml, P = 0.022 at 6 months; 25 ± 16 vs 30 ± 17 ml, P = 0.021 at 12 months) were observed with echocardiography in these patients 6-month after the treatment with catechin. Ejection fraction, left ventricular wall thickness, biatrial dimension remained unchanged. No significant side effects were observed in the patients tested.

CONCLUSIONS:

This study indicates that Ca2+ desensitizing green tea extract catechin, is helpful in correcting the impaired relaxation in pediatric cardiomyopathy patients with diastolic dysfunction.

KEYWORDS:

Diastolic dysfunction; Green tea extract catechin; Hypertrophic cardiomyopathy; Restrictive cardiomyopathy

PMID:
31064352
PMCID:
PMC6505250
DOI:
10.1186/s12929-019-0528-7
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central Icon for NYU School of Medicine Icon for Vanderbilt University - Eskind Biomedical Library, Nashville, TN
Loading ...
Support Center